Finance

Beta
Lists
TEN:FRA
Tecan Group AG
€170.20
-0.18%
(-0.30) 1D
Jun 3, 8:04:29 AM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for TEN...
Open
€170.20
High
€170.20
Low
€170.20
Mkt. cap
2.00B
Avg. vol.
0.00
Volume
0.00
52-wk high
€185.10
52-wk low
€122.20
No. of employees
3K
Open
€170.20
High
€170.20
Low
€170.20
Mkt. cap
2.00B
Avg. vol.
0.00
Volume
0.00
52-wk high
€185.10
52-wk low
€122.20
No. of employees
3K
News stories
From sources across the web
Profile
Tecan Group Ltd. is a Swiss company providing laboratory instruments and solutions in biopharmaceuticals, forensics, clinical diagnostics and medical technology for pharmaceutical and biotechnology companies, university research departments, diagnostic laboratories and clinics. The company specializes in laboratory automation. As an original equipment manufacturer, it develops and manufactures OEM instruments, components and medical devices that are then distributed by partner companies. Founded in Switzerland, in 1980, the company has over 3,500 employees, owns production and research and development sites in North America, Europe and APAC and maintains a sales and service network in 52 countries. In 2021, Tecan generated sales of CHF 946 million. Registered shares of Tecan Group are traded on the SIX Swiss Exchange. Wikipedia
About Tecan Group AG
CEO-
Employees3.17K
Founded1980
HeadquartersMännedorf, Zurich, Switzerland
SectorHealth care
Websitetecan.com
Previous reportsAll values in CHF
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CHF
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
219.74M
219.74M
221.50M
221.50M
Cost of goods sold
140.10M
140.10M
145.72M
145.72M
Cost of revenue
140.10M
140.10M
145.72M
145.72M
Research and development expenses
17.63M
17.63M
15.77M
15.77M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
51.74M
51.74M
48.44M
48.44M
Operating expense
68.07M
68.07M
64.86M
64.86M
Total operating expenses
208.17M
208.17M
210.58M
210.58M
Operating income
11.57M
11.57M
10.92M
10.92M
Other non operating income
-
-
-226.50K
-226.50K
EBT including unusual items
11.56M
11.56M
-62.19M
-62.19M
EBT excluding unusual items
11.56M
11.56M
9.47M
9.47M
Income tax expense
2.60M
2.60M
2.10M
2.10M
Effective tax rate
22.50%
22.50%
-3.37%
-3.37%
Other operating expenses
-1.30M
-1.30M
649.50K
649.50K
Net income
8.96M
8.96M
-64.29M
-64.29M
Net profit margin
4.08%
4.08%
-29.02%
-29.02%
Earnings per share
-
-
-
-
Interest and investment income
1.27M
1.27M
616.00K
616.00K
Interest expense
-770.00K
-770.00K
-664.00K
-664.00K
Net interest expenses
499.00K
499.00K
-48.00K
-48.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
24.12M
24.12M
16.31M
16.31M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more